Review

rhtrail (R&D Systems)

R&D Systems is a verified supplier

R&D Systems manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

R&D Systems rhtrail

Figure 1. <t>rhTRAIL</t> exposure effect alone and in combination with WT HSV-1 virus on HNSCC cell lines and the normal cell line, HaCaT. Treatment was performed with rhTRAIL at 100 ng/mL and in combination with WT HSV-1 virus at MOI 0f. 0.2 and 1.0. Cell viability analysis after 48 (A) and 72 h (B) of exposure. Results are expressed by mean percentage ± standard deviation of cell viability relative to PBS 1X (considering 100% viability). Data represent the average of three independent assays performed in triplicate. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by non-normal distribution Kruskal–Wallis test.

Rhtrail, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 132 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+trail+rhtrail+protein/Recombinant+Human+TRAIL%2FTNFSF10+Protein/pm37865660-166-10-12
Average 94 stars, based on 132 article reviews

rhtrail - by Bioz Stars, 2026-09

94/100 stars

Images

1) Product Images from "Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines."

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

Journal: Scientific reports

doi: 10.1038/s41598-023-44888-9

Figure 1. rhTRAIL exposure effect alone and in combination with WT HSV-1 virus on HNSCC cell lines and the normal cell line, HaCaT. Treatment was performed with rhTRAIL at 100 ng/mL and in combination with WT HSV-1 virus at MOI 0f. 0.2 and 1.0. Cell viability analysis after 48 (A) and 72 h (B) of exposure. Results are expressed by mean percentage ± standard deviation of cell viability relative to PBS 1X (considering 100% viability). Data represent the average of three independent assays performed in triplicate. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by non-normal distribution Kruskal–Wallis test.

Figure Legend Snippet: Figure 1. rhTRAIL exposure effect alone and in combination with WT HSV-1 virus on HNSCC cell lines and the normal cell line, HaCaT. Treatment was performed with rhTRAIL at 100 ng/mL and in combination with WT HSV-1 virus at MOI 0f. 0.2 and 1.0. Cell viability analysis after 48 (A) and 72 h (B) of exposure. Results are expressed by mean percentage ± standard deviation of cell viability relative to PBS 1X (considering 100% viability). Data represent the average of three independent assays performed in triplicate. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by non-normal distribution Kruskal–Wallis test.

Techniques Used: Virus, Standard Deviation, Comparison

Figure 2. Expression analysis of apoptosis-associated proteins in the HCB289 cell line after 24 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 1.

Figure Legend Snippet: Figure 2. Expression analysis of apoptosis-associated proteins in the HCB289 cell line after 24 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 1.

Techniques Used: Expressing, Standard Deviation, Control, Comparison

Figure 3. Expression analysis of apoptosis-associated proteins in the UD-SCC-2 cell line after 24 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 2.

Figure Legend Snippet: Figure 3. Expression analysis of apoptosis-associated proteins in the UD-SCC-2 cell line after 24 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 2.

Techniques Used: Expressing, Standard Deviation, Control, Comparison

Figure 4. Expression analysis of apoptosis-associated proteins in the HCB289 cell line after 48 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of two independent assays. The asterisks indicate statistical significance (*P < 0.05) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 3.

Figure Legend Snippet: Figure 4. Expression analysis of apoptosis-associated proteins in the HCB289 cell line after 48 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of two independent assays. The asterisks indicate statistical significance (*P < 0.05) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 3.

Techniques Used: Expressing, Standard Deviation, Control, Comparison

Figure 5. Expression analysis of apoptosis-associated proteins in the UD-SCC-2 cell line after 48 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of two independent assays. The asterisks indicate statistical significance (*P < 0.05) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 4.

Figure Legend Snippet: Figure 5. Expression analysis of apoptosis-associated proteins in the UD-SCC-2 cell line after 48 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of two independent assays. The asterisks indicate statistical significance (*P < 0.05) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 4.

Techniques Used: Expressing, Standard Deviation, Control, Comparison

Figure 6. Flow cytometry apoptosis analysis after treatment with rhTRAIL ligand, WT HSV-1 and in combination. A and B) Analysis of HCB289 cell line after 24 and 48 h of treatment exposure. C and D) Analysis of UD-SCC-2 cell line after 24 and 48 h of treatment exposure. Results are expressed as mean percentage ± standard deviation of the cell death rate. Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.001) in the comparison with the experimental groups by one-way ANOVA.

Figure Legend Snippet: Figure 6. Flow cytometry apoptosis analysis after treatment with rhTRAIL ligand, WT HSV-1 and in combination. A and B) Analysis of HCB289 cell line after 24 and 48 h of treatment exposure. C and D) Analysis of UD-SCC-2 cell line after 24 and 48 h of treatment exposure. Results are expressed as mean percentage ± standard deviation of the cell death rate. Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.001) in the comparison with the experimental groups by one-way ANOVA.

Techniques Used: Flow Cytometry, Standard Deviation, Comparison

Figure 7. DR-5 expression analysis in the HCB289 cell line after treatment with rhTRAIL ligand, WT-HSV-1 and combination. (A) and (B) Detection and quantification of the receptor after 24 h of exposure treatment. (C) and (D) Detection and quantification of the receptor after 48 h of exposure treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the protein α-tubulin. Data represent the average of two independent. Raw blots are presented in Supplementary Data 5.

Figure Legend Snippet: Figure 7. DR-5 expression analysis in the HCB289 cell line after treatment with rhTRAIL ligand, WT-HSV-1 and combination. (A) and (B) Detection and quantification of the receptor after 24 h of exposure treatment. (C) and (D) Detection and quantification of the receptor after 48 h of exposure treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the protein α-tubulin. Data represent the average of two independent. Raw blots are presented in Supplementary Data 5.

Techniques Used: Expressing, Standard Deviation, Control

Figure 8. DR-5 expression analysis in the UD-SCC-2 cell line after treatment with rhTRAIL ligand, WT-HSV-1 and combination. (A) and (B) Detection and quantification of the receptor after 24 h of exposure treatment. (C) and (D) Detection and quantification of the receptor after 48 h of exposure treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the protein α-tubulin. Data represent the average of two independent assays. Raw blots are presented in Supplementary Data 6.

Figure Legend Snippet: Figure 8. DR-5 expression analysis in the UD-SCC-2 cell line after treatment with rhTRAIL ligand, WT-HSV-1 and combination. (A) and (B) Detection and quantification of the receptor after 24 h of exposure treatment. (C) and (D) Detection and quantification of the receptor after 48 h of exposure treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the protein α-tubulin. Data represent the average of two independent assays. Raw blots are presented in Supplementary Data 6.

Techniques Used: Expressing, Standard Deviation, Control

Recombinant:

Article Title: TRAIL contributes to the apoptotic effect of 13- cis retinoic acid in human sebaceous gland cells
Article Snippet: .. Recombinant human TRAIL (rhTRAIL) protein (R&D Systems; Minneapolis, MN) was reconstituted in 0.1% BSA/PBS and stored at −80° C. TRAIL monoclonal antibody, GAPDH monoclonal antibody, β-actin antibody and anti-rabbit HRP linked secondary antibody were obtained from Cell Signaling Technology (Beverly, MA). .. TRAIL-R1 (DR4) mouse monoclonal antibody (Abcam, Cambridge, MA) and TRAIL-R2 (DR5) goat polyclonal (R&D Systems, Minneapolis, MN) were purchased.

Similar Products

rhtrail (R&D Systems)

R&D Systems rhtrail

Rhtrail, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+trail+rhtrail+protein/Recombinant+Human+TRAIL%2FTNFSF10+Protein/pm37865660-166-10-12
Average 94 stars, based on 1 article reviews

rhtrail - by Bioz Stars, 2026-09

94/100 stars

Buy from Supplier

rhtrail (R&D Systems Hematology)

R&D Systems Hematology rhtrail
$IFNα is cytotoxic to a subset of bladder cancer cell lines in multiple contexts (A) Schematic of adenoviral tool vectors. The Ad-IFNα2b vector includes hIFNα2b driven by a CMV promoter inserted into the E1 region and GFP driven by the RSV promoter inserted into the E3 region. The Ad-GFP vector includes an empty E1 region and GFP driven by the RSV promoter inserted into the E3 region. Both tool viruses lack viral E1 and E3. (B–G) Cells were exposed to (B) 100,000 U/mL rhIFNα2b, (C) 50 ng/mL TRAIL, (D) Ad-IFNα2b (MOI = 100), (E) Ad-GFP (MOI = 100) and conditioned media (CM) produced by (F) Ad-IFNα2b or (G) Ad-GFP transduced SV-HUC-1 cells. Cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Results are presented as mean ± SD from independent experiments performed in triplicate; N = 2 or 3 for Ad-GFP, N = 3 for all other treatments. (H) Pairwise correlation analysis was performed for all treatments and the Pearson correlation coefficient was determined. Bold indicates P < 0.05. (I) Cells were exposed to Ad-IFNα2b, Ad-GFP, or Ad-empty (MOI = 100 for all); cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Ad, adenovirus vector; CMV, cytomegalovirus; GFP, green fluorescent protein; rhIFNα2b, recombinant human interferon alpha 2b, <t>rhTRAIL,</t> recombinant human TNF-related apoptosis-inducing ligand; RSV, respiratory syncytial virus; SV40 Poly(A), simian virus 40 polyadenylated tail.$
Rhtrail, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+trail+rhtrail+protein/Recombinant+Human+TRAIL%2FTNFSF10+Protein/pmc08645427-199-17-18
Average 94 stars, based on 1 article reviews

rhtrail - by Bioz Stars, 2026-09

94/100 stars

Buy from Supplier

human recombinant trail protein rhtrail (R&D Systems)

R&D Systems human recombinant trail protein rhtrail
$IFNα is cytotoxic to a subset of bladder cancer cell lines in multiple contexts (A) Schematic of adenoviral tool vectors. The Ad-IFNα2b vector includes hIFNα2b driven by a CMV promoter inserted into the E1 region and GFP driven by the RSV promoter inserted into the E3 region. The Ad-GFP vector includes an empty E1 region and GFP driven by the RSV promoter inserted into the E3 region. Both tool viruses lack viral E1 and E3. (B–G) Cells were exposed to (B) 100,000 U/mL rhIFNα2b, (C) 50 ng/mL TRAIL, (D) Ad-IFNα2b (MOI = 100), (E) Ad-GFP (MOI = 100) and conditioned media (CM) produced by (F) Ad-IFNα2b or (G) Ad-GFP transduced SV-HUC-1 cells. Cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Results are presented as mean ± SD from independent experiments performed in triplicate; N = 2 or 3 for Ad-GFP, N = 3 for all other treatments. (H) Pairwise correlation analysis was performed for all treatments and the Pearson correlation coefficient was determined. Bold indicates P < 0.05. (I) Cells were exposed to Ad-IFNα2b, Ad-GFP, or Ad-empty (MOI = 100 for all); cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Ad, adenovirus vector; CMV, cytomegalovirus; GFP, green fluorescent protein; rhIFNα2b, recombinant human interferon alpha 2b, <t>rhTRAIL,</t> recombinant human TNF-related apoptosis-inducing ligand; RSV, respiratory syncytial virus; SV40 Poly(A), simian virus 40 polyadenylated tail.$
Human Recombinant Trail Protein Rhtrail, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+trail+rhtrail+protein/Recombinant+Human+TRAIL%2FTNFSF10+Protein%2C+CF/pmc07407704-53-3-11
Average 94 stars, based on 1 article reviews

human recombinant trail protein rhtrail - by Bioz Stars, 2026-09

94/100 stars

Buy from Supplier

recombinant human rhtrail r2 tnfrsf10b fc chimera protein (R&D Systems)

R&D Systems recombinant human rhtrail r2 tnfrsf10b fc chimera protein
$IFNα is cytotoxic to a subset of bladder cancer cell lines in multiple contexts (A) Schematic of adenoviral tool vectors. The Ad-IFNα2b vector includes hIFNα2b driven by a CMV promoter inserted into the E1 region and GFP driven by the RSV promoter inserted into the E3 region. The Ad-GFP vector includes an empty E1 region and GFP driven by the RSV promoter inserted into the E3 region. Both tool viruses lack viral E1 and E3. (B–G) Cells were exposed to (B) 100,000 U/mL rhIFNα2b, (C) 50 ng/mL TRAIL, (D) Ad-IFNα2b (MOI = 100), (E) Ad-GFP (MOI = 100) and conditioned media (CM) produced by (F) Ad-IFNα2b or (G) Ad-GFP transduced SV-HUC-1 cells. Cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Results are presented as mean ± SD from independent experiments performed in triplicate; N = 2 or 3 for Ad-GFP, N = 3 for all other treatments. (H) Pairwise correlation analysis was performed for all treatments and the Pearson correlation coefficient was determined. Bold indicates P < 0.05. (I) Cells were exposed to Ad-IFNα2b, Ad-GFP, or Ad-empty (MOI = 100 for all); cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Ad, adenovirus vector; CMV, cytomegalovirus; GFP, green fluorescent protein; rhIFNα2b, recombinant human interferon alpha 2b, <t>rhTRAIL,</t> recombinant human TNF-related apoptosis-inducing ligand; RSV, respiratory syncytial virus; SV40 Poly(A), simian virus 40 polyadenylated tail.$
Recombinant Human Rhtrail R2 Tnfrsf10b Fc Chimera Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+trail+rhtrail+protein/Recombinant+Human+TRAIL+R2%2FTNFRSF10B+Fc+Chimera+Protein%2C+CF/pmc07215742-212-36-45
Average 93 stars, based on 1 article reviews

recombinant human rhtrail r2 tnfrsf10b fc chimera protein - by Bioz Stars, 2026-09

93/100 stars

Buy from Supplier

recombinant human trail tnfsf10 rhtrail (R&D Systems)

R&D Systems recombinant human trail tnfsf10 rhtrail
$IFNα is cytotoxic to a subset of bladder cancer cell lines in multiple contexts (A) Schematic of adenoviral tool vectors. The Ad-IFNα2b vector includes hIFNα2b driven by a CMV promoter inserted into the E1 region and GFP driven by the RSV promoter inserted into the E3 region. The Ad-GFP vector includes an empty E1 region and GFP driven by the RSV promoter inserted into the E3 region. Both tool viruses lack viral E1 and E3. (B–G) Cells were exposed to (B) 100,000 U/mL rhIFNα2b, (C) 50 ng/mL TRAIL, (D) Ad-IFNα2b (MOI = 100), (E) Ad-GFP (MOI = 100) and conditioned media (CM) produced by (F) Ad-IFNα2b or (G) Ad-GFP transduced SV-HUC-1 cells. Cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Results are presented as mean ± SD from independent experiments performed in triplicate; N = 2 or 3 for Ad-GFP, N = 3 for all other treatments. (H) Pairwise correlation analysis was performed for all treatments and the Pearson correlation coefficient was determined. Bold indicates P < 0.05. (I) Cells were exposed to Ad-IFNα2b, Ad-GFP, or Ad-empty (MOI = 100 for all); cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Ad, adenovirus vector; CMV, cytomegalovirus; GFP, green fluorescent protein; rhIFNα2b, recombinant human interferon alpha 2b, <t>rhTRAIL,</t> recombinant human TNF-related apoptosis-inducing ligand; RSV, respiratory syncytial virus; SV40 Poly(A), simian virus 40 polyadenylated tail.$
Recombinant Human Trail Tnfsf10 Rhtrail, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+trail+rhtrail+protein/Recombinant+Human+TRAIL%2FTNFSF10+(E%2E+coli-expressed)+Protein/pmc06298406-115-0-20
Average 90 stars, based on 1 article reviews

recombinant human trail tnfsf10 rhtrail - by Bioz Stars, 2026-09

90/100 stars

Buy from Supplier

recombinant human trail rhtrail (R&D Systems)

R&D Systems recombinant human trail rhtrail
$IFNα is cytotoxic to a subset of bladder cancer cell lines in multiple contexts (A) Schematic of adenoviral tool vectors. The Ad-IFNα2b vector includes hIFNα2b driven by a CMV promoter inserted into the E1 region and GFP driven by the RSV promoter inserted into the E3 region. The Ad-GFP vector includes an empty E1 region and GFP driven by the RSV promoter inserted into the E3 region. Both tool viruses lack viral E1 and E3. (B–G) Cells were exposed to (B) 100,000 U/mL rhIFNα2b, (C) 50 ng/mL TRAIL, (D) Ad-IFNα2b (MOI = 100), (E) Ad-GFP (MOI = 100) and conditioned media (CM) produced by (F) Ad-IFNα2b or (G) Ad-GFP transduced SV-HUC-1 cells. Cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Results are presented as mean ± SD from independent experiments performed in triplicate; N = 2 or 3 for Ad-GFP, N = 3 for all other treatments. (H) Pairwise correlation analysis was performed for all treatments and the Pearson correlation coefficient was determined. Bold indicates P < 0.05. (I) Cells were exposed to Ad-IFNα2b, Ad-GFP, or Ad-empty (MOI = 100 for all); cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Ad, adenovirus vector; CMV, cytomegalovirus; GFP, green fluorescent protein; rhIFNα2b, recombinant human interferon alpha 2b, <t>rhTRAIL,</t> recombinant human TNF-related apoptosis-inducing ligand; RSV, respiratory syncytial virus; SV40 Poly(A), simian virus 40 polyadenylated tail.$
Recombinant Human Trail Rhtrail, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+trail+rhtrail+protein/Recombinant+Human+TRAIL%2FTNFSF10+(E%2E+coli-expressed)+Protein/ppr0062911-151-5-9
Average 90 stars, based on 1 article reviews

recombinant human trail rhtrail - by Bioz Stars, 2026-09

90/100 stars

Buy from Supplier

Image Search Results

Journal: Scientific reports

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

doi: 10.1038/s41598-023-44888-9

Figure Lengend Snippet: Figure 1. rhTRAIL exposure effect alone and in combination with WT HSV-1 virus on HNSCC cell lines and the normal cell line, HaCaT. Treatment was performed with rhTRAIL at 100 ng/mL and in combination with WT HSV-1 virus at MOI 0f. 0.2 and 1.0. Cell viability analysis after 48 (A) and 72 h (B) of exposure. Results are expressed by mean percentage ± standard deviation of cell viability relative to PBS 1X (considering 100% viability). Data represent the average of three independent assays performed in triplicate. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by non-normal distribution Kruskal–Wallis test.

Article Snippet: :(0123456789) Scientific Reports | (2023) 13:18023 | https://doi.org/10.1038/s41598-023-44888-9 treated with rhTRAIL (#375-TL, R&D Systems, Minneapolis, MN, EUA) at 100 ng/mL, HSV-1 MOI 0.2 and/ or HSV-1 MOI 1.

Techniques: Virus, Standard Deviation, Comparison

Journal: Scientific reports

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

doi: 10.1038/s41598-023-44888-9

Figure Lengend Snippet: Figure 2. Expression analysis of apoptosis-associated proteins in the HCB289 cell line after 24 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 1.

Techniques: Expressing, Standard Deviation, Control, Comparison

Journal: Scientific reports

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

doi: 10.1038/s41598-023-44888-9

Figure Lengend Snippet: Figure 3. Expression analysis of apoptosis-associated proteins in the UD-SCC-2 cell line after 24 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 2.

Techniques: Expressing, Standard Deviation, Control, Comparison

Journal: Scientific reports

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

doi: 10.1038/s41598-023-44888-9

Figure Lengend Snippet: Figure 4. Expression analysis of apoptosis-associated proteins in the HCB289 cell line after 48 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of two independent assays. The asterisks indicate statistical significance (*P < 0.05) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 3.

Techniques: Expressing, Standard Deviation, Control, Comparison

Journal: Scientific reports

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

doi: 10.1038/s41598-023-44888-9

Figure Lengend Snippet: Figure 5. Expression analysis of apoptosis-associated proteins in the UD-SCC-2 cell line after 48 h of exposure with rhTRAIL ligand, WT HSV-1 and in combination. (A) and (B) detection and quantification of proteins after treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the portion of total protein (non- cleaved). Data represent the average of two independent assays. The asterisks indicate statistical significance (*P < 0.05) in the comparison with the experimental groups by one-way ANOVA. Raw blots are presented in Supplementary Data 4.

Techniques: Expressing, Standard Deviation, Control, Comparison

Journal: Scientific reports

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

doi: 10.1038/s41598-023-44888-9

Figure Lengend Snippet: Figure 6. Flow cytometry apoptosis analysis after treatment with rhTRAIL ligand, WT HSV-1 and in combination. A and B) Analysis of HCB289 cell line after 24 and 48 h of treatment exposure. C and D) Analysis of UD-SCC-2 cell line after 24 and 48 h of treatment exposure. Results are expressed as mean percentage ± standard deviation of the cell death rate. Data represent the average of three independent assays. The asterisks indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.001) in the comparison with the experimental groups by one-way ANOVA.

Techniques: Flow Cytometry, Standard Deviation, Comparison

Journal: Scientific reports

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

doi: 10.1038/s41598-023-44888-9

Figure Lengend Snippet: Figure 7. DR-5 expression analysis in the HCB289 cell line after treatment with rhTRAIL ligand, WT-HSV-1 and combination. (A) and (B) Detection and quantification of the receptor after 24 h of exposure treatment. (C) and (D) Detection and quantification of the receptor after 48 h of exposure treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the protein α-tubulin. Data represent the average of two independent. Raw blots are presented in Supplementary Data 5.

Techniques: Expressing, Standard Deviation, Control

Journal: Scientific reports

Article Title: Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines.

doi: 10.1038/s41598-023-44888-9

Figure Lengend Snippet: Figure 8. DR-5 expression analysis in the UD-SCC-2 cell line after treatment with rhTRAIL ligand, WT-HSV-1 and combination. (A) and (B) Detection and quantification of the receptor after 24 h of exposure treatment. (C) and (D) Detection and quantification of the receptor after 48 h of exposure treatment. Results are expressed as mean percentage ± standard deviation of relative expression of cleaved protein relative to control (considering 100% expression) and normalized by the protein α-tubulin. Data represent the average of two independent assays. Raw blots are presented in Supplementary Data 6.

Techniques: Expressing, Standard Deviation, Control

$IFNα is cytotoxic to a subset of bladder cancer cell lines in multiple contexts (A) Schematic of adenoviral tool vectors. The Ad-IFNα2b vector includes hIFNα2b driven by a CMV promoter inserted into the E1 region and GFP driven by the RSV promoter inserted into the E3 region. The Ad-GFP vector includes an empty E1 region and GFP driven by the RSV promoter inserted into the E3 region. Both tool viruses lack viral E1 and E3. (B–G) Cells were exposed to (B) 100,000 U/mL rhIFNα2b, (C) 50 ng/mL TRAIL, (D) Ad-IFNα2b (MOI = 100), (E) Ad-GFP (MOI = 100) and conditioned media (CM) produced by (F) Ad-IFNα2b or (G) Ad-GFP transduced SV-HUC-1 cells. Cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Results are presented as mean ± SD from independent experiments performed in triplicate; N = 2 or 3 for Ad-GFP, N = 3 for all other treatments. (H) Pairwise correlation analysis was performed for all treatments and the Pearson correlation coefficient was determined. Bold indicates P < 0.05. (I) Cells were exposed to Ad-IFNα2b, Ad-GFP, or Ad-empty (MOI = 100 for all); cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Ad, adenovirus vector; CMV, cytomegalovirus; GFP, green fluorescent protein; rhIFNα2b, recombinant human interferon alpha 2b, rhTRAIL, recombinant human TNF-related apoptosis-inducing ligand; RSV, respiratory syncytial virus; SV40 Poly(A), simian virus 40 polyadenylated tail.$

Journal: Molecular Therapy Oncolytics

Article Title: Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance

doi: 10.1016/j.omto.2021.11.006

Figure Lengend Snippet: IFNα is cytotoxic to a subset of bladder cancer cell lines in multiple contexts (A) Schematic of adenoviral tool vectors. The Ad-IFNα2b vector includes hIFNα2b driven by a CMV promoter inserted into the E1 region and GFP driven by the RSV promoter inserted into the E3 region. The Ad-GFP vector includes an empty E1 region and GFP driven by the RSV promoter inserted into the E3 region. Both tool viruses lack viral E1 and E3. (B–G) Cells were exposed to (B) 100,000 U/mL rhIFNα2b, (C) 50 ng/mL TRAIL, (D) Ad-IFNα2b (MOI = 100), (E) Ad-GFP (MOI = 100) and conditioned media (CM) produced by (F) Ad-IFNα2b or (G) Ad-GFP transduced SV-HUC-1 cells. Cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Results are presented as mean ± SD from independent experiments performed in triplicate; N = 2 or 3 for Ad-GFP, N = 3 for all other treatments. (H) Pairwise correlation analysis was performed for all treatments and the Pearson correlation coefficient was determined. Bold indicates P < 0.05. (I) Cells were exposed to Ad-IFNα2b, Ad-GFP, or Ad-empty (MOI = 100 for all); cytotoxicity is reported as the relative fraction of dead cells after 48 h of treatment. Ad, adenovirus vector; CMV, cytomegalovirus; GFP, green fluorescent protein; rhIFNα2b, recombinant human interferon alpha 2b, rhTRAIL, recombinant human TNF-related apoptosis-inducing ligand; RSV, respiratory syncytial virus; SV40 Poly(A), simian virus 40 polyadenylated tail.

Article Snippet: The following other reagents were used in this study: rhIFNα2b (Stem Cell Technologies, 78,077), palbociclib (Cayman, 16,273), rhTRAIL (R&D 375-TL).

Techniques: Plasmid Preparation, Produced, Recombinant, Virus

Review

Structured Review

Images

1) Product Images from "Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines."

Related Articles

Recombinant:

Similar Products

Image Search Results